State Street Corp Capricor Therapeutics, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,466,685 shares of CAPR stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,466,685
Previous 1,842,800
20.41%
Holding current value
$11.8 Million
Previous $17.5 Million
16.72%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CAPR
# of Institutions
141Shares Held
12.3MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$18.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$13.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$7.74 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$4.43 Million0.0% of portfolio
-
Ubs Group Ag549KShares$4.42 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $196M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...